Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer

Ken Suzawa; Michael Offin; Adam J. Schoenfeld; Andrew J. Plodkowski; Igor Odintsov; Daniel Lu; William W. Lockwood; Maria E. Arcila; Charles M. Rudin; Alexander Drilon; Helena A. Yu; Gregory J. Riely; Romel Somwar; Marc Ladanyi

doi:10.1200/PO.19.00011

Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer

Ken Suzawa, Michael Offin, Adam J. Schoenfeld, Andrew J. Plodkowski, Igor Odintsov, Daniel Lu, William W. Lockwood, Maria E. Arcila, Charles M. Rudin, Alexander Drilon, Helena A. Yu, Gregory J. Riely, Romel Somwar, Marc Ladanyi

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Original language	English
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00011
Publication status	Published - 2019
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/PO.19.00011

Cite this

Suzawa, K., Offin, M., Schoenfeld, A. J., Plodkowski, A. J., Odintsov, I., Lu, D., Lockwood, W. W., Arcila, M. E., Rudin, C. M., Drilon, A., Yu, H. A., Riely, G. J., Somwar, R., & Ladanyi, M. (2019). Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer. JCO Precision Oncology, 3. https://doi.org/10.1200/PO.19.00011

Suzawa, K, Offin, M, Schoenfeld, AJ, Plodkowski, AJ, Odintsov, I, Lu, D, Lockwood, WW, Arcila, ME, Rudin, CM, Drilon, A, Yu, HA, Riely, GJ, Somwar, R & Ladanyi, M 2019, 'Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer', JCO Precision Oncology, vol. 3. https://doi.org/10.1200/PO.19.00011

@article{08b01af5aa284ddd965654e36299abbd,

title = "Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer",

author = "Ken Suzawa and Michael Offin and Schoenfeld, {Adam J.} and Plodkowski, {Andrew J.} and Igor Odintsov and Daniel Lu and Lockwood, {William W.} and Arcila, {Maria E.} and Rudin, {Charles M.} and Alexander Drilon and Yu, {Helena A.} and Riely, {Gregory J.} and Romel Somwar and Marc Ladanyi",

year = "2019",

doi = "10.1200/PO.19.00011",

language = "English",

volume = "3",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer

AU - Suzawa, Ken

AU - Offin, Michael

AU - Schoenfeld, Adam J.

AU - Plodkowski, Andrew J.

AU - Odintsov, Igor

AU - Lu, Daniel

AU - Lockwood, William W.

AU - Arcila, Maria E.

AU - Rudin, Charles M.

AU - Drilon, Alexander

AU - Yu, Helena A.

AU - Riely, Gregory J.

AU - Somwar, Romel

AU - Ladanyi, Marc

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85074301334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074301334&partnerID=8YFLogxK

U2 - 10.1200/PO.19.00011

DO - 10.1200/PO.19.00011

M3 - Article

AN - SCOPUS:85074301334

SN - 2473-4284

VL - 3

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -

Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this